1. Volume 67, Issue 2, Pages 370-398 (August 2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection 
Pietro Lampertico, Kosh Agarwal, Thomas Berg, Maria Buti, Harry L.A. Janssen, George Papatheodoridis, Fabien Zoulim, Frank Tacke Pietro Lampertico, Kosh Agarwal, Thomas Berg, Maria Buti, Harry L.A. Janssen, George Papatheodoridis, Fabien Zoulim, Frank Tacke 
Journal of Hepatology 
Volume 67, Issue 2, Pages (August 2017)
DOI: /j.jhep
Copyright © 2017 European Association for the Study of the Liver Terms and Conditions

2. Fig. 1
Natural history and assessment of patients with chronic HBV infection based upon HBV and liver disease markers. *Persistently or intermittently. °°HBV DNA levels can be between 2,000 and 20,000IU/ml in some patients without sings of chronic hepatitis.
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2017 European Association for the Study of the Liver Terms and Conditions

3. Fig. 2
Algorithm for the management of HBV infection. 1see definitions in text and Fig. 1.
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2017 European Association for the Study of the Liver Terms and Conditions

4. Fig. 3
Cumulative incidence of HBV resistance for lamivudine (LAM), adefovir (ADV), entecavir (ETV), telbivudine (TBV), tenofovir (TDF) and tenofovir alafenamide (TAF) in pivotal trials in nucleos(t)ide-naïve patients with chronic hepatitis B. (Collation of currently available data – not from head-to-head studies). No evidence of resistance has been shown after 8 years of TDF treatment.69
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2017 European Association for the Study of the Liver Terms and Conditions

5. Fig. 4
Week 12 and 24 stopping rules for HBeAg-positive and -negative patients treated with PegIFNα. These rules are based upon viral genotype, HBsAg and HBV levels.
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2017 European Association for the Study of the Liver Terms and Conditions